Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prevail Therapeutics Inc. (PRVL)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18
   10-K10-K
Net income  -63.2-19.1
Depreciation and amortization   [+]0.30.1
Stock-based compensation  4.31.6
Change in working capital   [+]1.91.8
Other operating activities  0.91.6
Cash from operations  -55.8-14.0
   
Capital expenditures  -2.1-0.6
Cash from investing  -2.1-0.6
   
Issuance of common stock, net  116.3 
Option exercises  0.1 
Other cash from financing  46.764.9
Cash from financing  162.964.9
   
Free cash flow  -57.9-14.6
        Per share (diluted)  ($2.03)($2.84)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy